Skip to main content

From Images to Data: Ten Years on, Tribun Health Opens a New Chapter in Digital Pathology

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

PARIS, FRANCE / ACCESS Newswire / November 5, 2026 / Tribun Health celebrated its tenth anniversary in Paris on Wednesday with employees, clients, partners and shareholders. More than a look back, the anniversary was an opportunity for the company to share its vision for the years ahead: going beyond slide digitization to bring images, diagnostic reports, data and artificial intelligence together on a single platform, while continuing to expand into international markets.

Founded in 2016 by Jacques Klossa and Jean-François Pomerol, Tribun Health develops CaloPix®, a digital pathology platform that enables laboratories and pathologists to manage, view and share diagnostic images, organize workflows and integrate artificial intelligence applications.

Over the past ten years, Tribun Health has expanded into several international markets, including Canada, the United Kingdom, Denmark, Sweden, Italy and Belgium. Its platform now supports more than 50 diagnostic organizations. CaloPix® is CE-IVDR certified in Europe and licensed by Health Canada. The platform has also received FDA 510(k) clearance in the United States and is now registered in Australia.

"Ten years ago, we were convinced that pathology would become digital. Today, that transformation is underway. Our next challenge is to go further: bringing images, diagnostic data and artificial intelligence together in one solution, so pathologists can make full use of this information in their day-to-day practice," said Jean-François Pomerol, CEO and co-founder of Tribun Health.

BEYOND THE IMAGE: ORGANIZING AND UNLOCKING THE VALUE OF PATHOLOGY DATA

Digitizing slides has opened up new possibilities for laboratories by improving access to images, collaboration and the organization of diagnostic work. The next step is to make better use of the information associated with those images.

By bringing images, their interpretation and diagnostic reports together-and progressively connecting them with other clinical, molecular and genomic data-Tribun Health aims to contribute to a more integrated approach to pathology in support of diagnosis, research and precision medicine.

Artificial intelligence is part of this evolution, bringing new analytical and decision-support capabilities while preserving the central role of the pathologist and their medical expertise.

A STRONG INTERNATIONAL PRESENCE AND NEW GROWTH OPPORTUNITIES

Building on its experience with laboratories and hospitals in several countries, Tribun Health aims to strengthen its position in existing markets and continue to scale its international operations.

This ambition responds in particular to the needs of hospital networks and multi-site pathology organizations seeking solutions that can harmonize practices, facilitate the sharing of expertise and adapt to diverse technology and regulatory environments.

To support this growth, Tribun Health is building on CaloPix®'s strengths: a platform that is independent of major scanner manufacturers, open to third-party artificial intelligence applications and designed to integrate with existing information systems.

"Pathology and cancer have no borders. For ten years, we have grown alongside our clients, learning from their realities and challenges. Our ambition is to support more pathology organizations around the world, giving them the freedom to choose the technologies best suited to their needs. Openness, interoperability and independence are central to who we are, and they will guide our future," said Jean-François Pomerol.

TEN YEARS OF INNOVATION AND SHARED COMMITMENT

The tenth-anniversary celebration was also an opportunity to recognize the people behind the company's story and bring together those who have contributed to Tribun Health's growth since its founding.

Behind every technological innovation are close-knit teams, lasting collaborations and trust built over time with physicians, clients and partners.

For the company's founders, the mission remains unchanged: to give pathologists the best tools to fully apply their expertise and help deliver increasingly precise patient care.

Discover the story of Tribun Health's first ten years through the voices of its employees, partners and clients: watch the film.

ABOUT TRIBUN HEALTH

Tribun Health is a French company specializing in digital pathology software solutions. Its CaloPix® platform enables pathology organizations to manage diagnostic workflows, view and share digitized slide images, and integrate artificial intelligence applications into their working environment.

Based in Paris and active internationally, Tribun Health supports private laboratories, hospitals and research organizations in their digital transformation.

MEDIA CONTACT

Andreia Beyer
abeyer@tribun.health

SOURCE: Tribun Health



View the original press release on ACCESS Newswire

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  258.22
-7.81 (-2.94%)
AAPL  342.86
-6.65 (-1.90%)
AMD  417.49
-71.29 (-14.59%)
BAC  49.93
-1.70 (-3.29%)
GOOG  281.88
-5.42 (-1.89%)
META  602.30
-27.70 (-4.40%)
MSFT  541.24
-14.56 (-2.62%)
NVDA  182.62
-17.51 (-8.75%)
ORCL  114.31
-9.42 (-7.61%)
TSLA  339.91
-45.28 (-11.76%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.